Mednax Inc Stock Technical Analysis
| MD Stock | USD 23.51 0.58 2.53% |
As of the 10th of May, the last recorded price for Mednax is 23.51 per share. Primary technical drivers reflect Mean Deviation of 1.77, downside deviation of 3.25, and Risk Adjusted Performance of 0.0853. Quantitative analysis incorporates volatility metrics and price behavior to assess directional bias. Metrics are compared to industry averages to assess relative positioning.
Mednax Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Mednax, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MednaxMednax |
Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 22.17 | Buy | 8 | Odds |
Analyst recommendations for Mednax Inc are summarized from various research providers. The average consensus rating provides a summary measure of analyst sentiment for Mednax. Professional analyst coverage of Mednax Inc provides individual investors with access to institutional-quality research. The spread between the highest and lowest Mednax price targets reflects the degree of analytical disagreement. A maintained buy rating with a target cut for Mednax Inc often signals deteriorating near-term expectations. The collective analyst view on Mednax provides a useful reference for individual investment decisions.
Quarterly Earnings Growth 50.0% | Earnings Share 2.06 | Revenue Per Share | Quarterly Revenue Growth 3.9% | Return On Assets |
Comparing Mednax's market price with book value reveals how market sentiment relates to accounting fundamentals. Mednax's market capitalization is 1.93 billion. A P/B ratio of 2.08 indicates the market values Mednax above its accounting book value. Enterprise value (TTM) stands at 2.12 billion. For Mednax, intrinsic value estimation helps reconcile what the market pays with what the books show.
Mednax's estimated value and market price are complementary but separate measures of worth. Mednax's trading price represents the transaction level agreed by market participants.
What-If Analysis
Running a what-if backtest on Mednax Inc provides a practical way to test how changes in horizon, position size, or market timing might have affected the result. The analytical value is perspective: it shows whether the thesis would have remained investable across different historical windows or depended too heavily on one favorable stretch.
| 02/09/2026 |
| 05/10/2026 |
Placing 0.00 into Mednax on February 9, 2026 with a hold through today would produce 0.00 in net return. This amounts to a 0.0% net return in Mednax on balance across a 90 day span. Mednax is related to or competes with National HealthCare, Select Medical, Acadia Healthcare, Astrana Health, Aveanna Healthcare, Ardent Health, and Lifestance Health. Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, a... More
Mednax Momentum Range Indicators Snapshot
Upside and downside measures for Mednax frame directional pressure and range behavior. Upside potential is measured relative to recent highs; downside exposure is framed against recent lows.
| Downside Deviation | 3.25 | |||
| Information Ratio | 0.0789 | |||
| Maximum Drawdown | 14.29 | |||
| Value At Risk | -2.97 | |||
| Potential Upside | 3.87 |
Volatility and Risk Indicators for Mednax Snapshot
Risk measures here provide context on Mednax's return distribution and drawdown behavior. Maximum drawdown and recovery time capture the worst-case loss profile and how quickly the price rebounds.| Risk Adjusted Performance | 0.0853 | |||
| Jensen Alpha | 0.2082 | |||
| Total Risk Alpha | 0.2128 | |||
| Sortino Ratio | 0.0643 | |||
| Treynor Ratio | 0.341 |
Mean reversion setups in Mednax emerge when price has deviated materially from its long-run average. Sentiment extremes, news events, or liquidity shocks are common catalysts for these temporary dislocations in Mednax. Prices periodically overshoot their intrinsic value in both directions, creating mean reversion opportunities in Mednax. The mean reversion signal gains reliability when combined with fundamental confirmation for Mednax.
Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0853 | |||
| Market Risk Adjusted Performance | 0.351 | |||
| Mean Deviation | 1.77 | |||
| Semi Deviation | 3.03 | |||
| Downside Deviation | 3.25 | |||
| Coefficient Of Variation | 1221.56 | |||
| Standard Deviation | 2.65 | |||
| Variance | 7.02 | |||
| Information Ratio | 0.0789 | |||
| Jensen Alpha | 0.2082 | |||
| Total Risk Alpha | 0.2128 | |||
| Sortino Ratio | 0.0643 | |||
| Treynor Ratio | 0.341 | |||
| Maximum Drawdown | 14.29 | |||
| Value At Risk | -2.97 | |||
| Potential Upside | 3.87 | |||
| Downside Variance | 10.56 | |||
| Semi Variance | 9.21 | |||
| Expected Short fall | -1.75 | |||
| Skewness | -1.55 | |||
| Kurtosis | 7.09 |
Mednax Inc Backtested Returns
Over the selected 3 months, Mednax demonstrates a very low volatility profile. It maintains a Sharpe Ratio (Efficiency) of 0.0823, representing adjusted performance consistency. We identified twenty-nine technical indicators influencing the company's volatility profile. Please analyze metrics such as mean deviation of 1.77, downside deviation of 3.25, and risk-adjusted performance of 0.0853 to assess dispersion and downside exposure. On a scale of 0 to 100, Mednax holds a performance score of 6. The company retains a Market Sensitivity (Beta) of 0.61, which means generally lower market sensitivity than the broad market. With a sub-1 beta, Mednax typically participates in market rallies at a reduced pace while often limiting downside exposure.
Auto-correlation | -0.38 |
Poor reverse predictability
Mednax Inc exhibits poor reverse predictability. Autocorrelation measures the degree of predictability between Mednax time series from 9th of February 2026 to 26th of March 2026 and from 26th of March 2026 to 10th of May 2026. Persistent correlation between intervals suggests underlying momentum patterns in Mednax that may carry forward. The measured coefficient of -0.38 means just about 38.0% of Mednax's recent price variance traces back to prior period behavior. Given that Mednax Inc has negative autocorrelation for the selected time horizon, market participants may evaluate potential contrarian price behavior over comparable future intervals.
| Correlation Coefficient | -0.38 | |
| Spearman Rank Test | -0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 0.78 |
This analysis reflects how Mednax behaves based on price and volume data. The toolkit covers moving averages, momentum oscillators, and trend-based signals.
Technical Analysis
This analysis covers twenty-five data points across the selected time horizon. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Mednax Inc volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Technical Analysis Methodology & Indicators
Technical analysis of Mednax evaluates price structure, momentum, and volatility clustering. Volume and liquidity conditions influence signal reliability. Reduced trading volume may increase short-term pricing variability. Mednax has a market cap of 1.93 billion, P/E of 89.39, ROE of 20.89%.
Mednax Inc values are built from periodic company reporting and market reference feeds, with reporting definitions aligned before display. Analyst inputs may be included when coverage is available.
Editorial review and methodology oversight provided by: Rifka Kats, Member of Macroaxis Editorial Board
Technical Indicators
Technical analysis of Mednax Inc is useful because it frames whether the current trend still looks durable or is beginning to weaken. A disciplined technical workflow separates stronger setups from noisier price action.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0853 | |||
| Market Risk Adjusted Performance | 0.351 | |||
| Mean Deviation | 1.77 | |||
| Semi Deviation | 3.03 | |||
| Downside Deviation | 3.25 | |||
| Coefficient Of Variation | 1221.56 | |||
| Standard Deviation | 2.65 | |||
| Variance | 7.02 | |||
| Information Ratio | 0.0789 | |||
| Jensen Alpha | 0.2082 | |||
| Total Risk Alpha | 0.2128 | |||
| Sortino Ratio | 0.0643 | |||
| Treynor Ratio | 0.341 | |||
| Maximum Drawdown | 14.29 | |||
| Value At Risk | -2.97 | |||
| Potential Upside | 3.87 | |||
| Downside Variance | 10.56 | |||
| Semi Variance | 9.21 | |||
| Expected Short fall | -1.75 | |||
| Skewness | -1.55 | |||
| Kurtosis | 7.09 |
May 10, 2026 Daily Trend Indicators
Technical analysis of Mednax Inc is useful because it frames whether the current trend still looks durable or is beginning to weaken. A disciplined technical workflow separates stronger setups from noisier price action.
| Accumulation Distribution | 0.03 | ||
| Daily Balance Of Power | 0.70 | ||
| Rate Of Daily Change | 1.03 | ||
| Day Median Price | 23.33 | ||
| Day Typical Price | 23.39 | ||
| Price Action Indicator | 0.48 | ||
| Market Facilitation Index | 0.83 |